Prodrug Therapies for Infectious and Neurodegenerative Diseases is a research paper published in Pharmaceutics (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 AI145342, R01 Al158160, T32 NS105594, R01 NS36126 (HEG), P01 NS31492; R01NS034239; P01 MH64570; P30 MH062261
NINDS NIH HHS
Grant: R01 NS036126
NIMH NIH HHS
Grant: P01 MH064570
NIAID NIH HHS
Grant: R01 AI158160
NINDS NIH HHS
Grant: P01 NS031492
NIMH NIH HHS
Grant: R01 MH121402
NINDS NIH HHS
Grant: R01 NS034239
NIAID NIH HHS
Grant: R01 AI145542
NIMH NIH HHS
Grant: P30 MH062261
NIA NIH HHS
Grant: RF1 AG079138
National Institutes of Health
Grant: 5P01NS031492-05
MOLECULAR MECHANISM OF HIV-1-MEDIATED ENCEPHALOPATHY
National Institutes of Health
Grant: 5R01NS034239-26
Neuroprotective Immunity and HIV Dementia
National Institutes of Health
Grant: 1T32NS105594-01
Neuroimmunology of Disease Training Program
National Institutes of Health
Grant: 5P30MH062261-17
Chronic HIV Infection and Aging in NeuroAIDS (CHAIN) Center
National Institutes of Health
Grant: 1P01MH064570-01
Targeted Neuroprotection for HIV-1 Associated Dementia
National Institutes of Health
Grant: 5R01AI158160-03
LASER ART for PreP
National Institutes of Health
Grant: 3R01NS036126-01S2
HIV-1, MONOCYTES AND THE BLOOD/BRAIN BARRIER
FWCI
0.72
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals